Progesterone Treatment Experience in a Patient with Lymphangioleiomyomatosis Presenting with Recurrent Pneumothorax

Basit Öğe Kaydı
dc.contributor.authorTülek, Baykal
dc.contributor.authorKanat, Fikret
dc.contributor.authorSüerdem, Mecit
dc.date.accessioned2020-03-26T18:48:48Z
dc.date.available2020-03-26T18:48:48Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractLymphangioleiomyomatosis (LAM) is a rare interstitial lung disease. Patients with LAM generally present with dyspnea and spontaneous pneumothorax. Today, while there is no proven medical treatment method for LAM, progesterone is among the widely used drugs. In this report, the effect of approximately 1 year of progesterone treatment in a patient with LAM, presenting with recurrent pneumothorax, was evaluated.en_US
dc.identifier.endpage202en_US
dc.identifier.issn1302-4922en_US
dc.identifier.issue3en_US
dc.identifier.startpage199en_US
dc.identifier.urihttp://www.trdizin.gov.tr/publication/paper/detail/TWpJNE1qRTRPQT09
dc.identifier.urihttps://hdl.handle.net/20.500.12395/30426
dc.identifier.volume16en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofSolunumen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectSolunum Sistemien_US
dc.titleProgesterone Treatment Experience in a Patient with Lymphangioleiomyomatosis Presenting with Recurrent Pneumothoraxen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu